Newsmeme!
Discover News you didn't know existed
Palliative Treatment
News
Related Video News
No related video news stories found.
Related Videos
No related videos found.
Helsinn Healthcare And Zealand Pharma Sign A Partnering Agreement For ZP1846, A Novel GLP-2 Agonist
Published December 2, 2008, 2:06 am, ChemicalOnline
Helsinn Healthcare's Top management recently announced that it has signed a partnering agreement with Zealand Pharma, for the development and worldwide commercialization of ZP1846, a GLP-2 (glucagon-like peptide-2) receptor agonist which provides a novel way to treat chemotherapy-induced diarrhea (CID), a debilitating condition affecting patients undergoing cancer treatment with a range of ...
Maggie Mahar: What Does Health Care "Reform" Mean? How Soon Can We Get There? Part 1
Published December 1, 2008, 1:55 pm, HuffingtonPost
Forces calling for health care reform are gaining momentum. But if by "reform," they simply mean "universal coverage," I have to disagree.
Two Studies Show Benefits of Removing Tumor Tissue in the Spine Prior to Adjuntive Treatments
Published December 1, 2008, 1:47 pm, Centre Daily Times
Two studies, presented this week at the 94 th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA), concluded a novel technique can improve outcomes for patients with vertebral compression fractures (VCF) caused by malignant tumors in the spine. The American Cancer Society estimates 30 to 70 percent of more than half a million people who die annually of ...
Two Studies Show Benefits of Removing Tumor Tissue in the Spine Prior to Adjuntive Treatments
Published December 1, 2008, 1:30 pm, Business Wire via Yahoo! Finance
CHICAGO----Two studies, presented this week at the 94th Scientific Assembly and Annual Meeting of the Radiological Society of North America , concluded a novel technique can improve outcomes for patients with vertebral compression fractures caused by malignant tumors in the spine.
S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic ...
Published December 1, 2008, 12:00 pm, PR Newswire via Yahoo! Finance
S*BIO Pte Ltd today announced the initiation of a Phase 1/2 clinical trial of SB1518, a potent and orally-active JAK2 inhibitor, in leading medical centers in Australia for patients with chronic idiopathic myelofibrosis .
Help make the holidays special
Published December 1, 2008, 6:37 am, The Peterborough Examiner
The Global Angel Charity Organization is seeking donations to help send an ill 11-year-old Toronto boy to Georgetown, Guyana, to visit his family for the [...]
Do Good Corner: Hospice provides invaluable end-of-life care
Published December 1, 2008, 3:42 am, Times Herald
I never really knew what Hospice was all about until we used the service to care for my grandmother. The one thing that always will stand out in my mind is the night she died.
The U.S.'s $18.8-Billion Global AIDS Initiative--5 Years Later
Published December 1, 2008, 3:12 am, Scientific American
SOWETO, SOUTH AFRICA--The Perinatal HIV Research Unit (PHRU) at the sprawling Chris Hani Baragwanath Hospital here is abuzz with activity. Young women with swelling bellies wait in plastic chairs to see nurses while pharmacists distribute antiretroviral drugs from an office behind a metal security gate. Upstairs, a fresh coat of paint is being applied to the walls of a new men's clinic that ...
Briefly in Tompkins
Published December 1, 2008, 2:37 am, The Ithaca Journal
The Share the Warmth campaign is about to start distribution to those in need and are facing a shortfall of coats, especially children's coats. The community is being asked to donate gently used or new winter coats, hats, gloves, mittens, boots, and blankets.
Wyeth, Progenics report positive results from phase III study of Relistor
Published November 30, 2008, 10:50 pm, PharmaBiz
Wyeth Pharmaceuticals, a division of Wyeth, and Progenics Pharmaceuticals, Inc. said their phase III clinical study investigating Relistor (methylnaltrexone bromide) subcutaneous injection to treat opioid-induced constipation (OIC) in patients with chronic, non-cancer pain achieved statistical significance for the primary and key secondary efficacy endpoints.
Related News Resources:
> HGH News
News Directory
Get started fast by using a pre-defined news directory category
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |